| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 211915-06-9 | 達(dá)比加群酯 | N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-; Dabigatran etexilate; N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-beta-alanine ethyl ester |  | C34H41N7O5 | 詳情 | 供應(yīng)商 |
| 872728-81-9 | 達(dá)比加群酯; 甲磺酸達(dá)比加群酯 | N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-y; Dabigatran etexilate mesylate; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat; Pradaxa |  | C35H45N7O8S | 詳情 | 供應(yīng)商 |
| 211914-51-1 | 達(dá)比加群; 達(dá)比加群; 達(dá)比加群酯DABIGATRANETEXILATEMESILATE(研發(fā)中); 達(dá)比加群,400G; 達(dá)比加群,400G,5萬 | 3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methyl-benzoimidazole-5-carbonyl]-pyridin-2-yl-amino]; 3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methyl-benzoimidazole-5-carbonyl]-pyridin-2-yl-amino]propanoic acid; Dabigatran; Dabigatran Etexilate Mesilate; BIBR 953; 3-[[2-[[(4-carbaMiMidoylphenyl)aMino]Methyl]-1-Met |  | C25H25N7O3 | 詳情 | 供應(yīng)商 |
| 212321-78-3 | DESETHYL DABIGATRAN ETEXILATE; 去乙基達(dá)比加群酯 | Desethyl Dabigatran Etexilate; Desethyl Dabigatran Etexilate; Desethyl Pradaxa; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine | 無 | C32H37N7O5 | 詳情 | 供應(yīng)商 |
| 1422435-41-3 | 達(dá)比加群酯雜質(zhì)C | ethyl 3-(2-(((4-carbamoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carbo; Dabigatran impurity C |  | C25H28N6O4 | 詳情 | 供應(yīng)商 |
| 1408238-40-3 | 達(dá)比加群酯雜質(zhì)E | ; Dabigatran impurity E |  | C34H40N6O6 | 詳情 | 供應(yīng)商 |
| 1408238-41-4 | 達(dá)比加群酯雜質(zhì)F | ; Dabigatran impurity F |  | C19H21N5O2 | 詳情 | 供應(yīng)商 |
| 1580491-16-2 | 達(dá)比加群酯雜質(zhì)H | ; Dabigatran impurity H |  | C32H38N8O4 | 詳情 | 供應(yīng)商 |
| 1408238-36-7 | 達(dá)比加群酯雜質(zhì)I | ; Dabigatran impurity I |  | C26H33N5O4 | 詳情 | 供應(yīng)商 |
| 1408238-37-8 | 達(dá)比加群酯雜質(zhì)J | ; Dabigatran impurity J |  | C32H36N6O6 | 詳情 | 供應(yīng)商 |
| 1610758-22-9 | 達(dá)比加群酯雜質(zhì)O | 無 | C34H41N7O5 | 詳情 | 供應(yīng)商 | |
| 1702936-92-2 | 達(dá)比加群酯雜質(zhì)H | 無 | 詳情 | 供應(yīng)商 | ||
| 255706-13-9 | 達(dá)比加群酯雜質(zhì)I | 無 | 詳情 | 供應(yīng)商 | ||
| 1610758-20-7 | 達(dá)比加群酯雜質(zhì)L | 無 | 詳情 | 供應(yīng)商 | ||
| 211915-00-3 | 達(dá)比加群酯雜質(zhì)O | 無 | 詳情 | 供應(yīng)商 | ||
| 1900865-84-0 | 達(dá)比加群酯雜質(zhì)19 | 無 | 詳情 | 供應(yīng)商 | ||
| 1643392-59-9 | 達(dá)比加群酯雜質(zhì)27 | 無 | 詳情 | 供應(yīng)商 | ||